Pre-Filled Syringes Market Forecast 2016-2026 : Prospects for Leading Companies in Plastic Pre-Filled Syringes, Pen Injector & Autoinjectors, and Glass Pre-Filled Syringes

プレフィルドシリンジの世界市場:プラスチック製プレフィルドシリンジ、ペン型注射器、オートインジェクター、ガラス製プレフィルドシリンジ

◆タイトル:Pre-Filled Syringes Market Forecast 2016-2026 : Prospects for Leading Companies in Plastic Pre-Filled Syringes, Pen Injector & Autoinjectors, and Glass Pre-Filled Syringes
◆商品コード:VGAIN6041539
◆調査・発行会社:visiongain
◆発行日:2016年3月
◆ページ数:206
◆レポート形式:PDF / 英語
◆納品方法:Eメール
◆調査対象地域:グローバル
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名利用)GBP1,999 ⇒換算¥299,850見積依頼/購入/質問フォーム
Five UserGBP2,999 ⇒換算¥449,850見積依頼/購入/質問フォーム
Site License(全社内共有可)GBP4,999 ⇒換算¥749,850見積依頼/購入/質問フォーム
※Single UserとDept Licence(Five User)の場合、DRM(デジタル著作権管理)付PDFファイルです。認証されたPC上のみでの閲覧と、PDF閲覧期限は購入日より1年となります。Dept Licence(Five User)は印刷できますが、Single Userは印刷できません。Site Licence/Global Site Licenseの場合は、閲覧・印刷制限はありません。
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はvisiongainの日本における正規販売代理店です。

【レポートの概要】

本調査レポートでは、"プレフィルドシリンジの世界市場:プラスチック製プレフィルドシリンジ、ペン型注射器、オートインジェクター、ガラス製プレフィルドシリンジ"について調査・分析し、レポートサマリー、市場動向、世界市場規模・市場予測、地域別市場分析、主要国別市場分析、市場環境分析、専門家の見解、主要企業分析、結論などの情報をお届けいたします。

What can be expected from the pre-filled syringes market? Which areas are going to grow at the fastest rates? This visiongain report shows you potential revenues to 2026, assessing data, trends, opportunities and prospects there.
Our 206-page report provides 123 tables, charts, and graphs. Discover the most lucrative areas in the industry and the future market prospects. Our new study lets you assess forecasted sales at overall regional market and national level. You will see financial results, an interview, trends, opportunities, and revenue predictions. There is much opportunity in this fast moving market.

Forecasts from 2016-2026 and other analyses show you commercial prospects
Besides revenue forecasting to 2026, our new study provides you with recent results, growth rates, and market shares. Discover qualitative analyses (including SWOT and STEP analysis) and commercial developments.

See revenue forecasts for the leading submarkets and indications
How will submarkets perform to 2026? Our study forecasts revenues in the following national submarkets:
• National and Regional Markets
• Leading Therapeutic Sectors
• Leading Pre-Filled Device Therapies
• Pre-Filled Syringe and Related Technology Manufacturers

Leading companies and potential for market growth
Overall revenue for the Pre-filled syringe market will reach $6,940m in 2020, our work forecasts. We predict strong revenue growth through to 2026. A number of new injectable drugs and advances in technology are seen as factors driving growth over the forecast period.

Our work analyses the key companies in the market. See visiongain’s analysis of 14 leading companies, including these:
• Becton, Dickinson and Company
• Gerresheimer
• Schott
• Baxter
• Nipro
• Weigao
• Unilife
• Roselabs
• SHL Group
• Ypsomed
• Haselmeier
• Owen Mumford
• Bespak
• Datwyler

A company profile gives you the following information where available:
• Discussion of a company’s activities and outlook
• Company news relevant to the market
• Historical revenues

Discover capabilities, progress, and commercial prospects, helping you stay ahead.

What issues will affect the Pre-Filled Syringe industry?
Our new report discusses issues and events affecting the pre-filled syringe market. You will find discussions, including qualitative analyses on a range of topics.
You will see discussions of technological, commercial, and economic matters, with emphasis on the competitive landscape and business outlooks.

How the Pre-Filled Syringes Market 2016-2026 report helps you
In summary, our 206-page report gives you the following knowledge:
• Revenue forecasts to 2026 for the Pre-Filled Syringes market – discover the industry’s prospects, finding promising places for investments and revenues
• Revenue forecasts to 2026 for the leading national markets – US, Japan, EU5, BRIC
• Revenue forecasts to 2026 for submarkets – discover prospects for leading therapeutic areas, as well as products within these areas. Identify the key trends driving and restraining growth in the market, including government policy and economic conditions relevant to the market.
• Assessment of 14 leading companies – historical revenue, news and upcoming product releases
• Discussion of what stimulates and restrains the market

【レポートの目次】

1. Report Overview
1.1. Global Pre-Filled Syringes Market Overview
1.2. Global Pre-Filled Syringes Market Segmentation
1.3. Why You Should Read This Report
1.4. How This Report Delivers
1.5. Key Questions Answered by This Analytical Report
1.6. Who is This Report For?
1.7. Methodology
1.8. Frequently Asked Questions (FAQ)
1.9. Associated Visiongain Reports
1.10. About Visiongain

2. Introduction to Pre-Filled Syringes
2.1. What are Pre-Filled Syringes?
2.2. A Brief History of Pre-Filled Syringes
2.3. Design and Manufacture of Pre-Filled Syringes
2.3.1. Glass and Plastic Syringes
2.3.2. Safety and the Pre-Filled Syringe Market
2.3.3. Concerns over Needlestick Injuries
2.4. An Introduction to Pen Injectors and Autoinjectors
2.4.1. Pen Injectors and Autoinjectors Offer Advantages in Self-Administration
2.4.2. What Determines Injection Device Choice?
2.5. Glass versus Plastic
2.5.1. Glass
2.5.2. Plastic
2.6. Future Directions for Pre-Filled Syringes
2.7. Pre-Filled Syringes: Market Segmentation
2.8. Scope of this Report
2.8.1. Products Excluded from this Report
2.9. Currency Exchange Rates in This Report

3. Pre-Filled Syringes: World Market 2016-2026
3.1. Pre-Filled Syringes as a Share of the Global Drug Delivery Market
3.2. The World Pre-Filled Syringes Market in 2015
3.2.1. World Pre-Filled Syringes Market: Market Shares by Segment 2015
3.2.2. Leading Companies in the Pre-Filled Syringes Market
3.3. World Pre-Filled Syringes Market: Sales Forecast by Value, 2016-2026
3.4. How Will Segmental Market Shares Change to 2026?
3.5. World Pre-Filled Syringes Market: Drivers and Restraints 2016-2026
3.5.1. Biologics and Biosimilars to Drive Market Growth
3.5.2. Human Factors and Regulatory Requirements
3.5.3. Advances in Pre-Filled Syringe Manufacturing
3.5.4. Market Genericisation and Pre-Filled Syringes
3.5.5. The Injectable Drug Pipeline is Substantial
3.5.6. Competing Drug Delivery Technologies
3.6. Glass Pre-Filled Syringes Lead the Pre-Filled Syringes Market
3.6.1. Glass Pre-Filled Syringes Market: Sales Forecast by Value, 2016-2026
3.6.2. Glass Pre-Filled Syringes: Drivers and Restraints 2016-2026
3.7. Plastic Pre-Filled Syringes: Rapid Growth Forecasted
3.7.1. Plastic Pre-Filled Syringes Market: Sales Forecast by Revenue, 2016-2026
3.7.2. Plastic Pre-Filled Syringes: Drivers and Restraints 2016-2026
3.8. Pen Injectors and Autoinjectors: A Growing Segment
3.8.1. Pen Injectors and Autoinjectors Market: Sales Forecast by Value, 2016-2026
3.8.2. Pen Injectors and Autoinjectors: Drivers and Restraints 2016-2026
3.8.3. Insulin and Other Biologics to Lead Market Growth

4. Leading National and Regional Markets 2016-2026
4.1. National Breakdown of the World Pre-Filled Syringes Market
4.2. World Pre-Filled Syringes Market: National Markets Forecast 2016-2026
4.2.1. How Will National Market Shares Change to 2026?
4.3. Regional Breakdown of the World Pre-Filled Syringes Market
4.4. World Pre-Filled Syringes Market: Regional Markets Forecast 2016-2026
4.4.1. How Will Regional Market Shares Change to 2026?
4.5. US Pre-Filled Syringes Market Forecast 2016-2026
4.5.1. US Pre-Filled Syringes Market: Trends and Developments
4.5.1.1. New Drug and Device Launches to Drive Growth to 2026
4.5.1.2. The Budget Control Act 2011 and the Medical Excise Tax
4.6. Japanese Pre-Filled Syringes Market Forecast 2016-2026
4.7. EU5 Pre-Filled Syringes Market Forecast 2016-2026
4.8. Emerging Markets: Pre-Filled Syringes Market Forecast 2016-2026
4.8.1. Pre-Filled Syringe Manufacturers Are Investing in Emerging Markets
4.8.2. Chinese Pre-Filled Syringes Market Forecast 2016-2026
4.8.3. Indian Pre-Filled Syringes Market Forecast 2016-2026
4.8.4. Russian Pre-Filled Syringes Market Forecast 2016-2026
4.8.5. Brazilian Pre-Filled Syringes Market Forecast 2016-2026

5. Leading Therapeutic Sectors for Pre-Filled Syringes 2016-2026
5.1. Leading Therapeutic Sectors for Pre-Filled Syringes and Other Injection Devices in 2015
5.1.1. Vaccines and Heparins Are Major Market Sectors
5.1.2. Rising Demand in Chronic Conditions: Autoimmune Diseases and Diabetes
5.1.3. Growth for Key Market Sectors 2016-2026
5.2. Pre-Filled Syringes and Pen Injectors for Diabetes 2016-2026
5.2.1. Insulin Market Forecast 2016-2026
5.2.2. High Rates of Pen Injector Use in the EU and Japan
5.2.3. Insulin Pumps: A Technology to Challenge Pen Injectors to 2026?
5.2.4. MannKind’s Afrezza: Inhalable Insulin Approved in US
5.2.5. Injection Devices for Biosimilar Insulin Products
5.3. Rheumatoid Arthritis: Leading Biologics Dominate the Market
5.3.1. Rheumatoid Arthritis Market Forecast 2016-2026
5.3.2. All Major Injectable Therapies Are Marketed in Proprietary Devices
5.3.3. Novel Injection Systems for RA: Meeting the Needs of Patients
5.3.4. The Receding Threat from Oral Therapies to 2026
5.4. Growth Hormones: Outlook to 2026
5.4.1. Growth Hormones Market Forecast 2016-2026
5.4.2. Biosimilar Growth Hormones and Pen Injectors
5.4.3. Uptake of Needle-Free Injectors for Growth Hormones
5.5. The Vaccine Market Outlook 2016-2026
5.5.1. Vaccine Market Forecast 2016-2026
5.5.2. Single-Use Devices for Vaccine Delivery
5.5.2.1. BD Uniject: A Private-Public Collaboration
5.5.3. Needle-Free Injectors for Vaccines
5.5.4. Other Trends in Vaccine Delivery
5.6. PCSK9 Inhibitors: The Next Advance in Cholesterol-Lowering Drugs
5.6.1. PCSK9 Inhibitors Market Forecast 2016-2026
5.6.2. PCSK9 Inhibitors and Pre-Filled Syringes/Injectors

6. Leading Pre-Filled Device Therapies 2016-2026
6.1. Leading Insulin Therapies Using Pen Injectors 2016-2026
6.1.1. Lantus: The World’s Best-Selling Insulin Analogue
6.1.1.1. SoloSTAR, ClikSTAR and AllSTAR: Three Pen Injectors for Lantus
6.1.1.2. Lantus: Sales Forecast 2016-2026
6.1.2. NovoLog: The Leading Fast-Acting Insulin
6.1.2.1. NovoLog FlexPen: To Be Retired
6.1.2.2. Novo’s New FlexTouch Pen Launched
6.1.2.3. NovoLog: Sales Forecast 2016-2026
6.1.3. Humalog
6.1.3.1. Humalog: HumaPen and KwikPen
6.1.3.2. Humalog: Sales Forecast 2016-2026
6.2. Top Biologics for Rheumatoid Arthritis: Device Outlook to 2026
6.2.1. Humira: The Biggest-Selling Drug in 2015
6.2.1.1. The Humira Pen Is an Innovative Delivery Device
6.2.1.2. Humira: Sales Forecast 2016-2026
6.2.2. Enbrel: The Leading Competitor to Humira
6.2.2.1. Pre-Filled Injection Devices Available for Enbrel in 2015
6.2.2.2. Enbrel: Sales Forecast 2016-2026
6.3. Growth Hormones: Two Products Dominated the Market in 2015
6.3.1. Norditropin: the Leading Growth Hormone
6.3.1.1. Norditropin: Sales Forecast 2016-2026
6.3.2. Genotropin: Sales Forecast 2016-2026
6.4. Outlook for Leading PCSK9 Products 2016-2026
6.4.1. Praluent (alirocumab, Sanofi/Regeneron)
6.4.1.1. Praluent: Sales Forecast 2016-2026
6.4.1.2. Amgen Suit Against Sanofi/Regeneron’s Praluent
6.4.2. Repatha (evolocumab, Amgen)
6.4.2.1. Repatha: Sales Forecast 2016-2026

7. Leading Pre-Filled Syringe and Related Technology Manufacturers, 2016
7.1. Leading Pre-Filled Syringe Manufacturers in 2015
7.1.1. Becton, Dickinson & Company: The Market Leader
7.1.1.1. Becton, Dickinson & Company: Pre-Filled Syringes Product Portfolio
7.1.1.2. BD Historical Revenue and Market Prospects
7.1.1.3. Recent Acquisitions by BD
7.1.1.4. BD Acquisition of CareFusion
7.1.1.5. BD AutoShield Duo Pen Needle Launched in 2014
7.1.2. Gerresheimer
7.1.2.1. Gerresheimer: Pre-Filled Syringes Product Portfolio
7.1.2.2. Gerresheimer Historical Revenue 2014-2015 and Market Outlook
7.1.2.3. Gerresheimer: Products in Development
7.1.2.4. Patent Application for Gerresheimer’s Gx G-Fix Adapter
7.1.2.5. Gerresheimer Commissioned to Manufacture Simponi Autoinjectors
7.1.2.6. Gerresheimer Opens First Development Center in China
7.1.3. Schott
7.1.3.1. Schott: Pre-Filled Syringes Product Portfolio
7.1.3.2. Schott Historical Revenue and Market Prospects
7.1.3.3. Schott: Expansion in India
7.2. Other Notable Pre-Filled Syringe Manufacturers
7.2.1. Baxter: Providing Contract Manufacturing with Pre-Filled Syringes
7.2.2. Nipro: Leading Japanese Contract Manufacturer
7.2.2.1. Nipro’s 2012 Acquisition of MGlas
7.2.3. Stevanato Group/Ompi: Insulin Vials Market Leader
7.2.4. Weigao: Pre-Filled Syringes for China and Beyond
7.2.5. Unilife: Pre-Filled Safety Syringes
7.2.6. Roselabs: Entered the Market in 2012
7.2.7. Vetter Pharma: Offering Lyo-Ject Dual-Chamber Syringes
7.2.8. Other Companies
7.3. Leading Pen Injector and Autoinjector Manufacturers in 2015
7.3.1. SHL Group
7.3.1.1. SHL Group: Pen Injectors and Autoinjectors Product Portfolio
7.3.1.2. SHL Group Market Prospects
7.3.2. Ypsomed
7.3.2.1. Ypsomed: Pen Injectors and Autoinjectors Product Portfolio
7.3.2.2. Ypsomed Historical Revenue and Market Prospects
7.3.2.3. Ypsomed: Recent Developments
7.3.3. Haselmeier
7.3.3.1. Haselmeier: Pen Injectors and Autoinjectors Product Portfolio
7.3.3.2. Haselmeier: Market Prospects
7.3.4. Owen Mumford
7.3.4.1. Owen Mumford: Pen Injectors and Autoinjectors Product Portfolio
7.3.5. Bespak: Entering the Auto-Injectors Market
7.3.6. Other Leading and Emerging Autoinjector Manufacturers
7.4. Leading Pre-Filled Syringe Component Manufacturers in 2016
7.4.1. Datwyler
7.4.1.1. Datwyler Historical Revenue and Market Prospects

8. Qualitative Analysis of the Pre-Filled Syringes Market 2016-2026
8.1. SWOT Analysis of the Pre-Filled Syringes Market
8.2. Strengths
8.2.1. Pre-Filled Syringes and Pen/Autoinjectors are Used In Chronic Conditions
8.2.2. Device Manufacturers Offer a Range Of Products
8.2.3. Customisation and Product Differentiation
8.2.4. Effective Lifecycle Management
8.3. Weaknesses
8.3.1. Patients with Needle Phobia
8.3.2. Chronic Diseases May Make Pre-Filled Syringes Difficult to Use
8.3.3. Risk of Extractables and Leachables
8.3.4. Higher Cost and Greater Cold Chain and Storage Requirements
8.4. Opportunities
8.4.1. Biosimilars Represent a Growing Market
8.4.2. Viscous and Large-Volume Drugs Require Novel Devices
8.4.3. Technological Developments Expanding Product Portfolios
8.4.4. Many Injectable Drugs in the Pipeline
8.4.5. Growth in Emerging Markets
8.5. Threats
8.5.1. Alternative Technologies: Needle-Free and Bolus Injectors
8.5.2. New Oral Therapies for Many Chronic Conditions
8.5.3. Increasing Regulatory Barriers
8.5.4. Cost Pressures on Healthcare Payers
8.6. STEP Analysis of the Pre-Filled Syringes Market
8.6.1. Social Factors: Rising Disease Incidence and Demand for At-Home Care
8.6.2. Technological Developments: Improved Safety and Administration
8.6.3. Economic Pressures: Pre-Filled Syringes Are Cost Efficient
8.6.3.1. High Barriers to Market Entry Exist
8.6.4. Political Issues: Regulatory Developments for Pre-Filled Syringes
8.7. Regulatory and Safety Outlook for Pre-Filled Syringes, 2016-2026
8.7.1. Needlestick Safety and Prevention
8.7.2. International Regulations for Needlestick Prevention
8.7.2.1. The US: The First Country to Introduce Needlestick Legislation
8.7.2.2. The EU: New Rules from 2013 Onwards
8.7.2.3. Needlestick Safety in Japan
8.7.2.4. Legislation for Needlestick Safety in Emerging Markets
8.7.3. Manufacturers Will Continue to Develop New Devices for Needlestick Prevention
8.7.3.1. Ancillary versus Integrated Safety Devices
8.7.4. Extractables and Leachables
8.7.4.1. Companies Will Reduce Sources of Extractables and Leachables
8.7.4.2. Products that Minimise Extractables and Leachables
8.7.4.3. Protein Aggregation: The Challenge of Biological Drugs
8.7.4.4. Regulatory Requirements for Extractables and Leachables
8.8. Biologics and the Pre-Filled Syringes Market, 2016-2026
8.8.1. Manufacturing Pre-Filled Syringes for Biologics: Glass versus Plastic
8.8.2. Biologics Provide New Challenges for Device Manufacturers
8.8.2.1. Lyophilised Drugs and Dual-Chamber Devices
8.8.3. Delivery Opportunities for High Viscosity Drugs
8.8.4. Are Biosimilars an Opportunity for Pre-Filled Syringe Manufacturers?
8.9. The Role of Patients in Pre-Filled Syringe Industry Development and Growth
8.9.1. Chronic Disease Incidence 2016-2026
8.9.2. The Rise in At-Home Care
8.9.3. Improving Patient Adherence
8.9.4. Injection Devices Must be Developed for Patient Convenience: Human Factors Engineering
8.10. Technological Developments in Pre-Filled Syringes to 2026
8.10.1. Product Differentiation Will be Vital in Crowded Treatment Markets
8.10.2. Product Customisation: Adapting Injection Devices
8.10.3. Trends in Manufacturing Materials for Pre-Filled Syringes
8.10.4. Competing Technologies Will Challenge Pre-Filled Syringes
8.10.4.1. Will Needle-Free Devices Become a Significant Competing Technology?
8.10.4.2. Patients Prefer Oral Drug Delivery
8.11. Outsourcing in the Pre-Filled Syringe Industry
8.11.1. Contract Medical Device Manufacturing
8.11.2. Contract Filling of Pre-Filled Syringes

9. Research Interviews
9.1. Interview with Nemera
9.1.1. Drivers and Restraints in the Pre-Filled Syringes Market
9.1.2. State of the Emerging Markets
9.1.3. Greatest Unmet Need in the Market
9.1.4. Therapeutic Areas Set to Benefit
9.1.5. Therapeutic Areas Set to Benefit
9.1.6. Nemera’s Safe’n’Sound Products
9.1.7. Other Nemera Products

10. Conclusions
10.1. Pre-Filled Syringes and Pen/Autoinjectors: Strong Growth Expected
10.2. The World Pre-Filled Syringes Market in 2015
10.2.1. Current Leading Pre-Filled Syringes Segments
10.2.2. Leading Pre-Filled Syringes Companies
10.2.3. Leading National and Regional Markets
10.3. World Pre-Filled Syringes Market Forecast 2016-2026
10.4. The Future of the Pre-Filled Syringes Market?
10.4.1. Glass Syringes Will Continue to Dominate
10.4.2. Innovation for Growth

11. Glossary

List of Tables
Table 2.1 Currency Exchange Rates, 2015
Table 3.1 World Pre-Filled Syringes Market Forecast: Revenues ($m), AGR (%) and CAGR (%) by Segment, 2015-2026
Table 3.2 Market Shares (%) of Leading Pre-Filled Syringes Market Segments, by Revenue, 2015, 2020 and 2026
Table 3.3 Glass Pre-Filled Syringes Market Forecast: Revenues ($m), AGR (%) and CAGR (%), 2015-2026
Table 3.4 Selected Proprietary Polymers for Plastic Pre-Filled Syringes, 2015
Table 3.5 Plastic Pre-Filled Syringes Market Forecast: Revenues ($m), AGR (%) and CAGR (%), 2015-2026
Table 3.6 Pen Injectors and Autoinjectors Market Forecast: Revenues ($m), AGR (%) and CAGR (%), 2015-2026
Table 4.1 World Pre-Filled Syringes Market: Revenues ($m) and Market Shares (%) by National Market, 2015
Table 4.2 World Pre-Filled Syringes Market Forecast: Revenues ($m), AGR (%) and CAGR (%) by National Market, 2015-2026
Table 4.2 World Pre-Filled Syringes Market Forecast: Revenues ($m), AGR (%) and CAGR (%) by National Market, 2015-2026 (continued)
Table 4.3 Market Shares (%) of Leading National Pre-Filled Syringes Markets, 2015, 2020 and 2026
Table 4.4 World Pre-Filled Syringes Market: Revenues ($m) and Market Shares (%) by Regional Market, 2015
Table 4.5 World Pre-Filled Syringes Market Forecast: Revenues ($m), AGR (%) and CAGR (%) by Regional Market, 2015-2026
Table 4.6 Market Shares (%) of Leading Regional Pre-Filled Syringes Markets, 2015, 2020 and 2026
Table 4.7 US Pre-Filled Syringes Market Forecast: Revenues ($m), AGR (%) and CAGR (%), 2015-2026
Table 4.8 Japanese Pre-Filled Syringes Market Forecast: Revenues ($m), AGR (%) and CAGR (%), 2015-2026
Table 4.9 EU5 Pre-Filled Syringes Market Forecast: Revenues ($m), AGR (%) and CAGR (%) by National Market, 2015-2026
Table 4.10 Chinese Pre-Filled Syringes Market Forecast: Revenues ($m), AGR (%) and CAGR (%), 2015-2026
Table 4.11 Indian Pre-Filled Syringes Market Forecast: Revenues ($m), AGR (%) and CAGR (%), 2015-2026
Table 4.12 Russian Pre-Filled Syringes Market Forecast: Revenues ($m), AGR (%) and CAGR (%), 2015-2026
Table 4.13 Brazilian Pre-Filled Syringes Market Forecast: Revenues ($m), AGR (%) and CAGR (%), 2015-2026
Table 5.1 Pen Manufacturing Agreements for Leading Insulin Brand Manufacturers, 2015
Table 5.2 Selected Biosimilar Insulin Pen Injectors, 2016
Table 5.3 Insulin Market Forecast: Revenues ($m), AGR (%) and CAGR (%), 2015-2026
Table 5.4 Rheumatoid Arthritis Market Forecast: Revenues ($m), AGR (%) and CAGR (%), 2015-2026
Table 5.5 Growth Hormone Therapies in Pen Injectors, 2016
Table 5.6 Growth Hormones Market Forecast: Revenues ($m), AGR (%) and CAGR (%), 2015-2026
Table 5.7 Selected Biosimilar Growth Hormones in Emerging Markets, 2016
Table 5.8 Vaccines Market Forecast: Revenues ($m), AGR (%) and CAGR (%), 2015-2026
Table 5.9 PCSK9 Inhibitors Market Forecast: Revenues ($m), AGR (%) and CAGR (%), 2015-2026
Table 6.1 Leading Pre-Filled Insulin Therapies: Revenues ($m), AGR (%) and CAGR (%), 2010-2015
Table 6.2 Sanofi: Lantus Revenue ($m), AGR (%) and CAGR (%), 2015-2026
Table 6.3 Novo Nordisk: NovoLog Revenue ($m), AGR (%) and CAGR (%), 2015-2026
Table 6.4 Eli Lilly: Humalog Revenue ($m), AGR (%) and CAGR (%), 2015-2026
Table 6.5 Leading Pre-Filled Rheumatoid Arthritis Therapies: Revenues ($m), AGR (%) and CAGR (%), 2010-2015
Table 6.6 AbbVie/Eisai: Humira Revenue ($m), AGR (%) and CAGR (%), 2015-2026
Table 6.7 Amgen/Pfizer: Enbrel Revenue ($m), AGR (%) and CAGR (%), 2015-2026
Table 6.8 Leading Pre-Filled Growth Hormone Therapies: Revenues ($m), AGR (%) and CAGR (%), 2010-2015
Table 6.9 Novo Nordisk: Norditropin Revenue ($m), AGR (%) and CAGR (%), 2015-2026
Table 6.10 Pfizer: Genotropin Revenue ($m), AGR (%) and CAGR (%), 2015-2026
Table 6.11 Sanofi: Praluent Revenue ($m), AGR (%) and CAGR (%), 2015-2026
Table 6.12 Amgen: Repatha Revenue ($m), AGR (%) and CAGR (%), 2015-2026
Table 7.1 BD: Overview, 2016
Table 7.2 BD: Pre-Filled Injection Systems, 2016
Table 7.3 BD: Pharmaceutical Systems Revenue ($m), AGR (%), CAGR (%), 2010-2015
Table 7.4 Gerresheimer: Overview, 2016
Table 7.5 Gerresheimer: Plastics & Devices and Primary Packaging Glass Segment Revenue ($m) for 2014 and 2015, plus AGR (%)
Table 7.6 Schott: Overview, 2016
Table 7.7 Schott: Net Revenue ($m), AGR (%) and CAGR (%), 2010-2015
Table 7.8 Unilife: Pre-Filled Syringe Product Portfolio, 2016
Table 7.9 Unilife: Net Revenue ($m), AGR (%) and CAGR (%), 2010-2015
Table 7.10 SHL Group: Overview, 2016
Table 7.11 SHL Group: Pen Injector and Autoinjector Portfolio, 2016
Table 7.12 Ypsomed: Overview, 2016
Table 7.13 Ypsomed: Pen Injector and Autoinjector Portfolio, 2016
Table 7.14 Ypsomed: Delivery Devices Revenue ($m), AGR (%) and CAGR (%), 2010-2015
Table 7.15 Haselmeier: Overview, 2016
Table 7.16 Haselmeier: Pen Injector and Autoinjector Portfolio, 2016
Table 7.17 Owen Mumford: Overview, 2016
Table 7.18 Owen Mumford: Pen Injector and Autoinjector Portfolio, 2016
Table 7.19 Datwyler: Overview, 2016
Table 7.20 Datwyler: Pharma Packaging Revenue ($m), AGR (%) and CAGR (%), 2010-2015
Table 8.1 Benefits and Weaknesses to Pre-Filled Syringes as an Injectable Delivery Device, 2016
Table 8.2 Pre-Filled Syringes Market: STEP Analysis, 2016-2026
Table 8.3 Selected Safety Products for Pre-Filled Syringes, 2016
Table 8.4 Selected Pre-Filled Injection Devices for Lyophilised Drugs, 2016
Table 8.5 Pre-Filled Syringe Manufacturers: Alternative Injectable Technologies, 2016
Table 8.6 Selected Insulin Pumps Available, 2016
Table 8.7 Oral Drug Competitors for Leading Pre-Filled Syringe Therapeutic Sectors, 2016-2026
Table 8.8 Selected Leading CMOs: Pre-Filled Syringe Filling Capabilities, 2016

List of Figures
Figure 1.1 Global Pre-Filled Syringes Market Segmentation Overview, 2016
Figure 2.1 Diagram of Syringe Parts, 2015
Figure 2.2 Timeline of Pre-Filled Syringe Development, 1950-2015
Figure 2.3 Major Trends for Pre-Filled Syringe Market Growth, 2016
Figure 3.1 World Pre-Filled Syringes Market: Market Shares (%) by Segment, 2015
Figure 3.2 World Pre-Filled Syringes Market Forecast: Revenues ($m) and AGR (%), 2015-2026
Figure 3.3 World Pre-Filled Syringes Market by Revenue: Market Shares (%) by Segment, 2015
Figure 3.4 World Pre-Filled Syringes Market by Revenue: Market Shares (%) by Segment, 2020
Figure 3.5 World Pre-Filled Syringes Market by Revenue: Market Shares (%) by Segment, 2026
Figure 3.6 World Pre-Filled Syringes Market: Drivers and Restraints, 2016-2026
Figure 3.7 Glass Pre-Filled Syringes Market Forecast: Revenues ($m) and AGR (%), 2015-2026
Figure 3.8 Glass Pre-Filled Syringes Market: Drivers and Restraints, 2016-2026
Figure 3.9 Plastic Pre-Filled Syringes Market Forecast: Revenues ($m) and AGR (%), 2015-2026
Figure 3.10 Plastic Pre-Filled Syringes Market: Drivers and Restraints, 2016-2026
Figure 3.11 Pen Injectors and Autoinjectors Market Forecast: Revenues ($m) and AGR (%), 2015-2026
Figure 3.12 Pen Injectors and Autoinjectors Market: Drivers and Restraints, 2016-2026
Figure 4.1 World Pre-Filled Syringes Market: Revenues ($m) by National Market, 2015
Figure 4.2 World Pre-Filled Syringes Market: Market Shares (%) by National Market, 2015
Figure 4.3 World Pre-Filled Syringes Market: Market Shares (%) by National Market, 2020
Figure 4.4 World Pre-Filled Syringes Market: Market Shares (%) by National Market, 2026
Figure 4.5 World Pre-Filled Syringes Market: Revenues ($m) by Regional Market, 2015
Figure 4.6 World Pre-Filled Syringes Market: Market Shares (%) by Regional Market, 2015
Figure 4.7 World Pre-Filled Syringes Market: Market Shares (%) by Regional Market, 2020
Figure 4.8 World Pre-Filled Syringes Market: Market Shares (%) by Regional Market, 2026
Figure 4.9 US Pre-Filled Syringes Market Forecast: Revenues ($m) and AGR (%), 2015-2026
Figure 4.10 Japanese Pre-Filled Syringes Market Forecast: Revenues ($m) and AGR (%), 2015-2026
Figure 4.11 EU5 Pre-Filled Syringes Market Forecast: Revenues ($m) by National Market, 2015-2026
Figure 4.12 Chinese Pre-Filled Syringes Market Forecast: Revenues ($m) and AGR (%), 2015-2026
Figure 4.13 Indian Pre-Filled Syringes Market Forecast: Revenues ($m) and AGR (%), 2015-2026
Figure 4.14 Russian Pre-Filled Syringes Market Forecast: Revenues ($m) and AGR (%), 2015-2026
Figure 4.15 Brazilian Pre-Filled Syringes Market Forecast: Revenues ($m) and AGR (%), 2015-2026
Figure 5.1 Insulin Market Forecast: Revenues ($m) and AGR (%), 2015-2026
Figure 5.2 Rheumatoid Arthritis Market Forecast: Revenues ($m) and AGR (%), 2015-2026
Figure 5.3 Growth Hormones Market Forecast: Revenues ($m) and AGR (%), 2015-2026
Figure 5.4 Vaccines Market Forecast: Revenues ($m) and AGR (%), 2015-2026
Figure 5.5 PCSK9 Inhibitors Market Forecast: Revenues ($m) and AGR (%), 2015-2026
Figure 6.1 Sanofi: Lantus Revenue ($m) and AGR (%), 2015-2026
Figure 6.2 Novo Nordisk: NovoLog Revenue ($m) and AGR (%), 2015-2026
Figure 6.3 Eli Lilly: Humalog Revenue ($m) and AGR (%), 2015-2026
Figure 6.4 AbbVie/Eisai: Humira Revenue ($m) and AGR (%), 2015-2026
Figure 6.5 Amgen/Pfizer: Enbrel Revenue ($m) and AGR (%), 2015-2026
Figure 6.6 Novo Nordisk: Norditropin Revenue ($m) and AGR (%), 2015-2026
Figure 6.7 Pfizer: Genotropin Revenue ($m) and AGR (%), 2015-2026
Figure 6.8 Sanofi/Regeneron: Praluent Revenue ($m) and AGR (%), 2015-2026
Figure 6.9 Amgen: Repatha Revenue ($m) and AGR (%), 2015-2026
Figure 7.1 BD: Pharmaceutical Systems Revenue ($m), AGR (%), 2010-2015
Figure 7.2 Gerresheimer: Plastics & Devices and Primary Packaging Glass Segment Revenue ($m), 2014 and 2015
Figure 7.3 Schott: Net Revenue ($m) and AGR (%), 2010-2015
Figure 7.4 Unilife: Net Revenue ($m) and AGR (%), 2010-2015
Figure 7.5 Ypsomed: Delivery Devices Revenue ($m) and AGR (%), 2010-2015
Figure 7.6 Datwyler: Pharma Packaging Revenue ($m) and AGR (%), 2010-2015
Figure 8.1 Pre-Filled Syringes Market: Strengths and Weaknesses, 2016-2026
Figure 8.2 Pre-Filled Syringes Market: Opportunities and Threats, 2016-2026
Figure 10.1 World Pre-Filled Syringes Market Forecast: Revenues ($m) by Segment, 2015-2026

【レポートのキーワード】

プレフィルドシリンジ、薬剤、注射器、プラスチック製プレフィルドシリンジ、ペン型注射器、オートインジェクター、ガラス製プレフィルドシリンジ

★調査レポート[プレフィルドシリンジの世界市場:プラスチック製プレフィルドシリンジ、ペン型注射器、オートインジェクター、ガラス製プレフィルドシリンジ] ( Pre-Filled Syringes Market Forecast 2016-2026 : Prospects for Leading Companies in Plastic Pre-Filled Syringes, Pen Injector & Autoinjectors, and Glass Pre-Filled Syringes / VGAIN6041539) 販売に関する免責事項
[プレフィルドシリンジの世界市場:プラスチック製プレフィルドシリンジ、ペン型注射器、オートインジェクター、ガラス製プレフィルドシリンジ] ( Pre-Filled Syringes Market Forecast 2016-2026 : Prospects for Leading Companies in Plastic Pre-Filled Syringes, Pen Injector & Autoinjectors, and Glass Pre-Filled Syringes / VGAIN6041539) についてEメールでお問い合わせ


◆H&Iグローバルリサーチ株式会社のお客様(例)◆